Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo

被引:206
|
作者
Francoz, S
Froment, P
Bogaerts, S
De Clercq, S
Maetens, M
Doumont, G
Bellefroid, E
Marine, JC
机构
[1] State Univ Ghent VIB, Lab Mol Canc Biol, B-9052 Ghent, Belgium
[2] Free Univ Brussels, Mol Embryol Lab, B-6041 Gosselies, Belgium
关键词
cre; lox;
D O I
10.1073/pnas.0508476103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Mdm2 and Mdm4 oncoproteins are key negative regulators of the p53 tumor suppressor. However, their physiological contributions to the regulation of p53 stability and activity remain highly controversial. Here, we combined a p53 knock-in allele, in which p53 is silenced by a transcriptional stop element flanked by loxP sites, with the mdm2- and mdm4-null alleles. This approach allows Cre-mediated conditional p53 expression in tissues in vivo and cells in vitro lacking Mdm2, Mdm4, or both. Using this strategy, we show that Mdm2 and Mdm4 are essential in a nonredundant manner for preventing p53 activity in the same cell type, irrespective of the proliferation/differentiation status of the cells. Although Mdm2 prevents accumulation of the p53 protein, Mdm4 contributes to the overall inhibition of p53 activity independent of Mdm2. We propose a model in which Mdm2 is critical for the regulation of p53 levels and Mdm4 is critical for the fine-tuning of p53 transcriptional activity, both proteins acting synergistically to keep p53 in check.
引用
收藏
页码:3232 / 3237
页数:6
相关论文
共 50 条
  • [41] Regulation of p53 and MDM2 activity by MTBP
    Brady, M
    Vlatkovic, N
    Boyd, MT
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (02) : 545 - 553
  • [42] P53 Mdm2 Inhibitors
    Khoury, Kareem
    Doemling, Alex
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (30) : 4668 - 4678
  • [43] MDM2与p53
    金晶
    刘耕陶
    [J]. 癌症, 2001, (06) : 663 - 666
  • [44] p53 and Mdm2: not all cells are equal
    Coates, P. J.
    [J]. JOURNAL OF PATHOLOGY, 2007, 213 (04): : 357 - 359
  • [45] Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
    Jiang, Liren
    Malik, Natasha
    Acedo, Pilar
    Zawacka-Pankau, Joanna
    [J]. CELL DEATH DISCOVERY, 2019, 5 (1)
  • [46] The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
    Manuela Argentini
    Nadia Barboule
    Bohdan Wasylyk
    [J]. Oncogene, 2001, 20 : 1267 - 1275
  • [47] The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
    Argentini, M
    Barboule, N
    Wasylyk, B
    [J]. ONCOGENE, 2001, 20 (11) : 1267 - 1275
  • [48] The p53-Mdm2 interaction and the E3 ligase activity of Mdm2/Mdm4 are conserved from lampreys to humans
    Coffill, Cynthia R.
    Lee, Alison P.
    Siau, Jia Wei
    Chee, Sharon M.
    Joseph, Thomas L.
    Tan, Yaw Sing
    Madhumalar, Arumugam
    Tay, Boon-Hui
    Brenner, Sydney
    Verma, Chandra S.
    Ghadessy, Farid J.
    Venkatesh, Byrappa
    Lane, David P.
    [J]. GENES & DEVELOPMENT, 2016, 30 (03) : 281 - 292
  • [49] Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
    Liren Jiang
    Natasha Malik
    Pilar Acedo
    Joanna Zawacka-Pankau
    [J]. Cell Death Discovery, 5
  • [50] The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
    Huang, Lei
    Yan, Zheng
    Liao, Xiaodong
    Li, Yuan
    Yang, Jie
    Wang, Zhu-Gang
    Zuo, Yong
    Kawai, Hidehiko
    Shadfan, Miriam
    Ganapathy, Suthakar
    Yuan, Zhi-Min
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (29) : 12001 - 12006